Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saskia M Wilting

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
Nature Medicine|September 4, 2025
Early versus deferred use of CDK4/6 inhibitors in advanced breast cancer: circulating tumor DNA analysis of a randomized phase 3 trialElisabeth M Jongbloed, Noor Wortelboer, Vanja de Weerd, et al.
Clinical Epigenetics|October 21, 2021
High-throughput and affordable genome-wide methylation profiling of circulating cell-free DNA by methylated DNA sequencing (MeD-seq) of LpnPI digested fragmentsTeoman Deger, Ruben G Boers, Vanja de Weerd, et al.
International Journal of Cancer|September 8, 2018
Genome-wide microRNA analysis of HPV-positive self-samples yields novel triage markers for early detection of cervical cancerBarbara C Snoek, Wina Verlaat, Iris Babion, et al.
Cancer Cell International|December 11, 2025
Methylated CfDNA may distinguish between high- and intermediate-risk uveal melanoma: a pilot studyMike Wu, Daniël P de Bruyn, Ruben G Boers, et al.
BMC Bioinformatics|June 23, 2018
Gene length corrected trimmed mean of M-values (GeTMM) processing of RNA-seq data performs similarly in intersample analyses while improving intrasample comparisonsMarcel Smid, Robert R J Coebergh van den Braak, Harmen J G van de Werken, et al.
Scientific Reports|March 29, 2018
Confirmation of a metastasis-specific microRNA signature in primary colon cancerRobert R J Coebergh van den Braak, Anieta M Sieuwerts, Zarina S Lalmahomed, et al.
American Journal of Respiratory and Critical Care Medicine|July 30, 2011
DNA copy number alterations in endobronchial squamous metaplastic lesions predict lung cancerRobert A A van Boerdonk, Thomas G Sutedja, Peter J F Snijders, et al.
Molecular Oncology|March 14, 2025
Cell-free DNA aneuploidy score as a dynamic early response marker in prostate cancerKhrystany T Isebia, Anouk C de Jong, Lisanne F van Dessel, et al.
Ebiomedicine|March 29, 2026
Prognostic value of peri-operative circulating tumour DNA levels estimated by cell-free DNA methylation in patients with resectable colorectal liver metastasesStavros Makrodimitris, Lissa Wullaert, Daan Hazelaar, et al.
Nature Genetics|October 2, 2019
The genomic landscape of metastatic breast cancer highlights changes in mutation and signature frequenciesLindsay Angus, Marcel Smid, Saskia M Wilting, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Nature Medicine|September 4, 2025
Early versus deferred use of CDK4/6 inhibitors in advanced breast cancer: circulating tumor DNA analysis of a randomized phase 3 trialElisabeth M Jongbloed, Noor Wortelboer, Vanja de Weerd, et al.
Clinical Epigenetics|October 21, 2021
High-throughput and affordable genome-wide methylation profiling of circulating cell-free DNA by methylated DNA sequencing (MeD-seq) of LpnPI digested fragmentsTeoman Deger, Ruben G Boers, Vanja de Weerd, et al.
International Journal of Cancer|September 8, 2018
Genome-wide microRNA analysis of HPV-positive self-samples yields novel triage markers for early detection of cervical cancerBarbara C Snoek, Wina Verlaat, Iris Babion, et al.
Cancer Cell International|December 11, 2025
Methylated CfDNA may distinguish between high- and intermediate-risk uveal melanoma: a pilot studyMike Wu, Daniël P de Bruyn, Ruben G Boers, et al.
BMC Bioinformatics|June 23, 2018
Gene length corrected trimmed mean of M-values (GeTMM) processing of RNA-seq data performs similarly in intersample analyses while improving intrasample comparisonsMarcel Smid, Robert R J Coebergh van den Braak, Harmen J G van de Werken, et al.
Scientific Reports|March 29, 2018
Confirmation of a metastasis-specific microRNA signature in primary colon cancerRobert R J Coebergh van den Braak, Anieta M Sieuwerts, Zarina S Lalmahomed, et al.
American Journal of Respiratory and Critical Care Medicine|July 30, 2011
DNA copy number alterations in endobronchial squamous metaplastic lesions predict lung cancerRobert A A van Boerdonk, Thomas G Sutedja, Peter J F Snijders, et al.
Molecular Oncology|March 14, 2025
Cell-free DNA aneuploidy score as a dynamic early response marker in prostate cancerKhrystany T Isebia, Anouk C de Jong, Lisanne F van Dessel, et al.
Ebiomedicine|March 29, 2026
Prognostic value of peri-operative circulating tumour DNA levels estimated by cell-free DNA methylation in patients with resectable colorectal liver metastasesStavros Makrodimitris, Lissa Wullaert, Daan Hazelaar, et al.
Nature Genetics|October 2, 2019
The genomic landscape of metastatic breast cancer highlights changes in mutation and signature frequenciesLindsay Angus, Marcel Smid, Saskia M Wilting, et al.
Pageof 9